MKI67 and breast carcinoma: The ER-negative tumour samples of our breast cancer cohort were examined for the association of miR-18a with the Ki67 proliferation index (the Ki67 proliferation index was determined by immunohistochemistry as elaborated in the manuscript published previously) [24].